THYROCARE TECHNOLOGIES
Back to Cashflow Statement
|
THYROCARE TECHNOLOGIES Last 5 Year Cash Flow from Financing Activities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Cash Flow from Financing Activities | ₹-130 Cr | ₹-85 Cr | ₹-86 Cr | ₹-89 Cr | ₹-62 Cr |
What is the latest Cash Flow from Financing Activities ratio of THYROCARE TECHNOLOGIES ?
| Year | Cash Flow from Financing Activities |
|---|---|
| Mar2025 | ₹-130 Cr |
| Mar2024 | ₹-85 Cr |
| Mar2023 | ₹-86 Cr |
| Mar2022 | ₹-89 Cr |
| Mar2021 | ₹-62 Cr |
How is Cash Flow from Financing Activities of THYROCARE TECHNOLOGIES Trending?
| Years | Cash Flow from Financing Activities | % Change | |
|---|---|---|---|
| Mar2025 | ₹-130 Cr | Negative | |
| Mar2024 | ₹-85 Cr | Negative | |
| Mar2023 | ₹-86 Cr | Negative | |
| Mar2022 | ₹-89 Cr | Negative | |
| Mar2021 | ₹-62 Cr | - | |
Compare Cash Flow from Financing Activities of peers of THYROCARE TECHNOLOGIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| THYROCARE TECHNOLOGIES | ₹6,539.9 Cr | 5.3% | -7.9% | 55.6% | Stock Analytics | |
| APOLLO HOSPITALS ENTERPRISE | ₹103,687.0 Cr | 1.8% | -2.1% | 5.3% | Stock Analytics | |
| MAX HEALTHCARE INSTITUTE | ₹98,267.8 Cr | 0.6% | -2% | -9.2% | Stock Analytics | |
| FORTIS HEALTHCARE | ₹67,293.2 Cr | 3.1% | -2.9% | 37.9% | Stock Analytics | |
| NARAYANA HRUDAYALAYA | ₹35,664.0 Cr | -0.6% | -8.8% | 26.7% | Stock Analytics | |
| GLOBAL HEALTH | ₹31,195.8 Cr | 4.2% | -3.4% | 9.3% | Stock Analytics | |
THYROCARE TECHNOLOGIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| THYROCARE TECHNOLOGIES | 5.3% |
-7.9% |
55.6% |
| SENSEX | 2.9% |
-1.1% |
8.5% |
You may also like the below Video Courses